KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Idexx Laboratories (IDXX) Leases (2019 - 2025)

Idexx Laboratories has reported Leases over the past 7 years, most recently at $123.2 million for Q4 2025.

  • Quarterly results put Leases at $123.2 million for Q4 2025, up 6.11% from a year ago — trailing twelve months through Dec 2025 was $123.2 million (up 6.11% YoY), and the annual figure for FY2025 was $123.2 million, up 6.11%.
  • Leases for Q4 2025 was $123.2 million at Idexx Laboratories, down from $128.2 million in the prior quarter.
  • Over the last five years, Leases for IDXX hit a ceiling of $129.8 million in Q2 2025 and a floor of $93.6 million in Q1 2021.
  • Median Leases over the past 5 years was $115.7 million (2023), compared with a mean of $114.9 million.
  • Biggest five-year swings in Leases: grew 27.08% in 2021 and later fell 3.24% in 2025.
  • Idexx Laboratories' Leases stood at $105.1 million in 2021, then grew by 12.86% to $118.6 million in 2022, then decreased by 2.63% to $115.5 million in 2023, then grew by 0.55% to $116.1 million in 2024, then rose by 6.11% to $123.2 million in 2025.
  • The last three reported values for Leases were $123.2 million (Q4 2025), $128.2 million (Q3 2025), and $129.8 million (Q2 2025) per Business Quant data.